New Dye Helps Early Diagnosis for Alzheimer’s Disease

AvidA new dye has been developed and has been proven to be able to detect Alzheimer’s disease in much earlier stages.

If the dye will be approved, it will become a step in having the first tool to pinpoint the disease.

Avid Radiopharmaceuticals coloring substance, called Florbetapir, contains the tracer Florbetapir F-18 which helps in the pinpointing process.

The testing done to help determine if the dye can help early diagnosis was that patients (with six months life expectancy) underwent a brain scan using the dye. After they died, it was found out that in the autopsy the dye are sticking to the right clumps of a protein called beta amyloid. Beta amyloid is postulated to be a fundamental cause of the disease.

Currently, Alzheimer’s disease can only be confirmed via autopsy. Doctors today only use memory tests, family histories, interviews with relatives and simple paper-and-pencil test as early detection procedures.